Search Results: keywords:"significant adverse effects"

  • H. R. 1963 — To require the heads of agencies identify whether major rules of the agency are budget neutral, and for other purposes.
    💰
    Status:Introduced in House
    Words:663

    H. R. 1963, also known as the "Agency Accountability and Cost Transparency Act of 2025," is a proposed law that requires heads of federal agencies to determine if their major rules are budget neutral before they are issued. A rule is considered budget neutral if the costs it...

    Simple Explanation

    The Agency Accountability and Cost Transparency Act of 2025 is a rule that says if a government office wants to make a big new rule that costs a lot of money, they need to stop another rule that costs the same amount, so everything is fair and balanced money-wise.

  • S. 483 — To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.
    Status:Introduced in Senate
    Words:709

    S. 483, titled the "Responsibility in Drug Advertising Act of 2025," seeks to amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising. The bill prohibits advertising a newly approved drug directly to consumers, including on social media...

    Simple Explanation

    S. 483 is a new rule that says companies can't show ads for new medicines on TV or the internet for the first three years they are available, but there might be a way to advertise sooner if it's important for people's health.